1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clinicians. 2021;71(3):209–49.
2. Zhu H, Ma X, Ye T, Wang H, Wang Z, Liu Q, Zhao K. Esophageal cancer in China: practice and research in the new era, international journal of cancer. J international du cancer. 2023;152(9):1741–51.
3. Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69(9):1564–71.
4. J He, WQ Chen, ZS Li, N Li, JS Ren, JH Tian, WJ Tian, FL Hu, J Peng, ED Expert Group of China Guideline for the Screening, C. Early Treatment of Esophageal, E.D. Work Group of China Guideline for the Screening, C. Early Treatment of Esophageal, [China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing)], Zhonghua zhong liu za zhi [Chinese journal of oncology]. 2022; 44:491–522.
5. Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME. The surveillance, epidemiology, and end results (SEER) program and pathology: toward strengthening the critical relationship. Am J Surg Pathol. 2016;40(12):e94–102.